Cargando…
CD84 is a Suppressor of T and B Cell Activation during Mycobacterium tuberculosis Pathogenesis
Interest in host-directed therapies as alternatives/adjuncts to antibiotic treatment has resurged with the increasing prevalence of antibiotic-resistant tuberculosis (TB). Immunotherapies that reinvigorate immune responses by targeting immune checkpoints like PD-1/PD-L1 have proved successful in can...
Autores principales: | Zheng, Nan, Fleming, Joy, Hu, Peilei, Jiao, Jianjian, Zhang, Guoqin, Yang, Ruifang, Li, Chuanyou, Liu, Yi, Bi, Lijun, Zhang, Hongtai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865571/ https://www.ncbi.nlm.nih.gov/pubmed/35196822 http://dx.doi.org/10.1128/spectrum.01557-21 |
Ejemplares similares
-
M. tuberculosis CRISPR/Cas proteins are secreted virulence factors that trigger cellular immune responses
por: Jiao, Jianjian, et al.
Publicado: (2021) -
Systematic Evaluation of Mycobacterium tuberculosis Proteins for Antigenic Properties Identifies Rv1485 and Rv1705c as Potential Protective Subunit Vaccine Candidates
por: Wang, Yaguo, et al.
Publicado: (2021) -
Identification of Serum microRNA Biomarkers for Tuberculosis Using RNA-seq
por: Zhang, Hongtai, et al.
Publicado: (2014) -
Omics analysis of Mycobacterium tuberculosis isolates uncovers Rv3094c, an ethionamide metabolism-associated gene
por: Wan, Li, et al.
Publicado: (2023) -
The β(2) clamp in the Mycobacterium tuberculosis DNA polymerase III αβ(2)ε replicase promotes polymerization and reduces exonuclease activity
por: Gu, Shoujin, et al.
Publicado: (2016)